Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vedanta Biosciences
AddedFeb 13, 2024
UpdatedJun 18, 2026
Vedanta Biosciences

Vedanta Biosciences

Series E

Vedanta Biosciences: An American biotech firm pioneering microbiome immune system drugs for immune diseases.

HQ
Cambridge, MA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Vedanta Biosciences, founded in Cambridge, Massachusetts, is an American biotech company focused on pioneering microbiome-based therapies for immune-mediated diseases. The company's core mission is to harness the power of the human microbiome to develop novel treatments that can modulate the immune system. Vedanta's product pipeline includes drug candidates targeting conditions such as Clostridioides difficile infections and inflammatory bowel disease (IBD), utilizing a proprietary platform to create defined microbial consortia.

Notable figures associated with Vedanta Biosciences include its co-founders and key investors like Pfizer, which has significantly backed the company. Among its key achievements, Vedanta has secured $106 million in funding to advance its Phase III clinical trial for C. difficile and Phase II trial for IBD. The company's innovative approach has positioned it as a leader in the microbiome therapeutics space, aiming to transform treatment paradigms for complex immune-related conditions.

Vedanta Biosciences - Similar Companies

Solarea Bio logo

Solarea Bio

solareabio.com

Petri Bio logo

Petri Bio

petribio.com

Vulcan Biologics logo

Vulcan Biologics

Curie.Bio logo

Curie.Bio

curie.bio

Vibe Bio logo

Vibe Bio

vibebio.com

Vetica Labs logo

Vetica Labs

MarvelBiome logo

MarvelBiome

marvelbiome.com

Walden Biosciences logo

Walden Biosciences

HI-Bio logo

HI-Bio

hibio.com

Viscient Bio logo

Viscient Bio

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Federation Bio logo

Federation Bio

federation.bio

Vir Biotechnology logo

Vir Biotechnology

vir.bio

Enveda Biosciences logo

Enveda Biosciences

envedabio.com

Fortis Biosciences logo

Fortis Biosciences

Vedanta Biosciences - Quick Facts

Who are Vedanta Biosciences' competitors?

Companies similar to Vedanta Biosciences include Solarea Bio, Petri Bio, Vulcan Biologics and Curie.Bio.

When was Vedanta Biosciences founded?

Vedanta Biosciences was founded in 2010.

Where is Vedanta Biosciences' headquarters located?

Vedanta Biosciences' headquarters is located in Cambridge, MA, US.

When was Vedanta Biosciences' last funding round?

Vedanta Biosciences' most recent funding round was for $106.5M (USD) in April 2023.

How much has Vedanta Biosciences raised to-date?

As of Apr 25, 2023, Vedanta Biosciences has raised a total of $433.1M (USD).

How many employees does Vedanta Biosciences have?

Vedanta Biosciences has 116 employees as of Feb 5, 2024.

Vedanta Biosciences - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Biotech
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research